Literature DB >> 17498855

Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season.

Taketo Otsuka1, Hidehiko Fujinaka, Koichi Katsuyama, Masashi Iizawa, Satoru Kinoshita, Yasuki Tanaka, Reiko Saito, Hiroshi Suzuki, Shuichi Tomizawa.   

Abstract

In this study, we report the effectiveness of trivalent inactivated influenza vaccination (TIV) for severely multiply handicapped persons/children (SMHPs) in the 2005-2006 season. In 77 SMHPs, A/New York/55/2004 (H3N2) which was the changed vaccine-strain showed significant differences in the geometric mean titers (P<0.05) and seroprotection rates (P<0.01) between pre- and post-vaccination. A/New Caledonia/20/99 (H1N1) and B/Shanghai/361/2002, which were the unchanged vaccine-strains, showed no significant differences. We defined the potential responders as those who can achieve 1:40 or more hemagglutination inhibition (HAI) titer after vaccination with any vaccine-strain. Therefore, the rate of potential responders is equivalent to the rate of seroprotection, estimated to be 40-60% among the SMHPs and >80% among the control group in this study. In the SMHPs, even potential responders could only achieve limited HAI titers (1:40-80) even after repeated vaccination. In contrast, the control group showed higher HAI titers compared to the SMHPs for the unchanged vaccine-strains caused by the priming effect. These data suggest that it might be difficult for SMHPs (including potential responders) to achieve the priming effect by the current TIV. Consequently, they cannot obtain a booster effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498855     DOI: 10.1016/j.vaccine.2007.03.041

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Influenza vaccination and treatment in children with neurologic disorders.

Authors:  Fiona Havers; Alicia Fry; Georgina Peacock; Lyn Finelli
Journal:  Ther Adv Vaccines       Date:  2014-07

2.  Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season.

Authors:  Megumi Hara; Tomoyuki Hanaoka; Kazuhiro Maeda; Tetsuo Kase; Satoko Ohfuji; Wakaba Fukushima; Yoshio Hirota
Journal:  J Epidemiol       Date:  2016-01-16       Impact factor: 3.211

Review 3.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

Review 4.  A novel influenza A (H1N1) outbreak experience among residents of a long term-care facility in Saudi Arabia during 2010 seasonal flu circulation.

Authors:  Raouf M Affifi; Sherif R Omar; Ahmad A El Raggal
Journal:  Infect Dis Rep       Date:  2012-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.